Diabetes

ARTICLES

For African Americans in poor Mississippi counties, having diabetes and kidney disease in combination lead to cardiovascular death rates that were on par with underdeveloped nations.
Zachary T. Bloomgarden, MD, MACE, highlights the appropriateness of certain agents for use in patients on statin therapy, based on evidence revealed in clinical trials.
Dennis P. Scanlon, PhD; Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; and John A. Johnson, MD, MBA, explain how new technologies (ie, applications on mobile devices) are useful in the management and care of patients with diabetes.
Dennis P. Scanlon, PhD; Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; Michael Gardner, MD; and John A. Johnson, MD, MBA, discuss the relevance of scientific evidence from clinical trials in the treatment decision-making process, the value of postmonitoring patients, and the significance and use of quality measures in helping to deliver data that can improve care for patients with diabetes who are at risk for cardiovascular events.
Zachary T. Bloomgarden, MD, MACE, remarks on controversies in clinical practice due to changes in lipid guidelines published by the American Heart Association and the American College of Cardiology.

EVENTS

April 12th, 2014
Hershey, PA
May 22nd to 25th , 2014
Fort Lauderdale, FL
August 14th to 16th, 2014
Stowe, VT
Compendia
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium
$AD300x250BB$
$vacMongoViewPlus$